Rana Zalmai

Dispense prescription medications, verify order accuracy, and evaluate drug interactions. Counsel patients on medication use and administer immunizations.

Assisted in teaching Pharmacy Practice Labs and Patient Counseling courses.

Designed and executed a commercial claims study evaluating predictors of buprenorphine treatment retention. Led and co-authored systematic literature and scoping reviews on PTSD treatment preferences, HIV PrEP care continuum, and pharmacist roles in psychedelic therapy.

Conducted systematic literature reviews and evidence-gap analyses for a rare liver disease program. Synthesized FDA guidance on patient-reported outcomes to inform outcome-measure selection for a Phase 3 trial.

Primary instructional responsibility for Biological Concepts and Personal and Community Health courses, serving predominantly non-traditional learners.

Led research on opioid and CNS depressant coprescription patterns. Contributed to Medicare claims study and evaluated polypharmacy and cognitive function in rural older adults.

Primary instructional responsibility for graduate-level health economics and drug literature evaluation coursework.

Doctor of Philosophy in Pharmaceutical Sciences with a concentration in Health Outcomes Research. Dissertation focused on social determinants of health and buprenorphine adherence among individuals with opioid use disorder.

Outcomes Research Fellowship in Pharmacotherapy. Major project assessed coprescription of opioids with central nervous system depressants for chronic pain management.

Grade: cum laude

Doctor of Pharmacy degree, graduated cum laude.

Bachelor of Science in Chemistry with minors in Biology and Healing & Humanities.